USPTO 2015–2025 USPTO PatentsView US Corporation

Essentium Ipco, LLC

USPTO PatentsView assignee record - 15 granted patents across 18 technology areas, recorded in grant years 2023–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ).

RSS updates for this company

The verdict

According to USPTO PatentsView, Essentium ranks #18,596 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 18 technology areas.

#18,596
of 49,997 US assignees by volume
Top 9%
by Innovation Score (53.0/100)
14.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R18596 · US Corporation #18,596 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 15 grants
  • MID-PACK #18,596/49,997
  • PHOTO-FINISH Enlivex Therapeutics…
  • CPC-FOCUS B33Y · 18 areas
  • INNOV-PAR 53.0/100
  • CLAIMS-RICH 14.0 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2023–2024 · 2y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Enlivex Therapeutics R&D Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Essentium’s 53.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Essentium

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Essentium's Innovation Score is 53.0/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Essentium?

Each dot is one of Essentium’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Essentium’s own 14.0 claims/patent is at or below the 17.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Essentium vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 51015202530 Granted patents (volume) Avg claims / patent Enlivex Therapeutics R&D Ltd - 15, 14.93Enlivex Therapeut…EOS Imaging - 15, 20.67EOS ImagingErasmus University Medical Center - 15, 17.8Erasmus Universit…Erco GMBH - 15, 6.73ErcoEtxe-tar, S.A. - 15, 20.4Etxe-tarEurecat S.A. - 15, 17.53EurecatExascaler Inc. - 15, 10.2ExascalerExini Diagnostics AB - 15, 26.13Exini Diagnostics…Essentium Ipco, LLC - 15, 14Essentium Ipco
Essentium vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Essentium's grants concentrate

Essentium Ipco, LLC is a focused PatentsView assignee: 18 CPC subclasses with 60% of grants classified under B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ). Peak complete grant year is 2023 (12 grants) versus a trough of 3 in 2024. By volume, Essentium sits between Enlivex Therapeutics R&D Ltd and Exini Diagnostics AB.

Essentium's three-year grant acceleration

Essentium Ipco, LLC shows 15 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Essentium's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Essentium holds 15 patents at rank #18,575, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Essentium

By rank, the assignees closest to #18,575 in granted patent volume.

Leaders in B33Y (Additive Manufacturing)

Other assignees with the most granted patents in Essentium's primary technology class.

Essentium's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

2468101214 20232024 3
USPTO utility patent grants by year · 2023–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table
Essentium Ipco, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2023 12 80.0%
2024 3 20.0%

Which technologies does Essentium Ipco, LLC patent most?

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Essentium Ipco, LLC's patent record in context - here's where to go next.

  • Essentium Ipco, LLC's lead technology class is B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ), 60% of its portfolio - see every assignee active in that class. Explore B33Y
  • Ranked #18,596 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Essentium Ipco, LLC against Enlivex Therapeutics R&D Ltd, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 53.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.